Business & Finance
GenSight Biologics provides update on cash position and operations
19 January 2021 - Biopharma company GenSight Biologics (Paris:SIGHT) (Euronext:SIGHT) (ISIN:FR0013183985) on Monday announced its cash and cash equivalents of EUR37.9m as of 31 December 2020 and will ...
Applied DNA Advances COVID-19 Diagnostics and Testing Activities
15 January 2021 - - US-based DNA manufacturing company Applied DNA Sciences, Inc's (NASDAQ: APDN) safeCircle pooled surveillance testing service has seen a 158% increase in the daily average numb...
Clovis Oncology reports estimated Rubraca global product revenues in the range of USD43.0m - USD43.5m for Q4 2020
12 January 2021 - Biopharmaceutical company Clovis Oncology Inc (NASDAQ:CLVS) on Monday announced estimated Rubraca global product revenues in the range of USD43.0m - USD43.5m for the fourth quarter o...
Hologic anticipates total revenues of about USD1,609.8m for Q1 fiscal 2021
11 January 2021 - Medical technology company Hologic Inc (Nasdaq:HOLX) on Friday reported total expected revenues of about USD1,609.8m for first fiscal quarter ended 26 December 2020 in advance of its...
Xbrane Biopharma renegotiates IP agreement with Vaxiion Therapeutics
5 January 2021 - Swedish biopharmaceutical company Xbrane Biopharma AB (STO:XBRANE) said on Tuesday that it has renegotiated a licence agreement with Vaxiion Therapeutics, a San Diego-based biopharmac...
Johnson & Johnson declares dividend of USD1.01 per share for Q1 2021
5 January 2021 - The board of directors of Johnson & Johnson (NYSE:JNJ) authorised a common stock cash dividend of USD1.01 per share for the first quarter of 2021, the company reported on Monday.W...